photo of

Details

Role Team Leader / Senior Research Officer

Contact

Available for student supervision
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.

Top Publications

  • Noé, A, Dang, TD, Axelrad, C, Burrell, E, Germano, S, Elia, S, Burgner, D, Perrett, KP, Curtis, N, Messina, NL. BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Frontiers in Immunology 14: 1242380 2024
    view publication
  • Zimmermann, P, Pittet, LF, Jakob, W, Messina, NL, Falquet, L, Curtis, N. The Effect of Bacille Calmette-Guérin Vaccination on the Composition of the Intestinal Microbiome in Neonates From the MIS BAIR Trial.. The Pediatric Infectious Disease Journal 2023
    view publication
  • Noble, CCA, Messina, NL, Pittet, LF, Curtis, N. Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19. The Journal of Infectious Diseases 228(10) : 1467 -1478 2023
    view publication
  • Pittet, LF, Moore, CL, McDonald, E, Barry, S, Bonten, M, Campbell, J, Croda, J, Dalcolmo, M, Davidson, A, Douglas, MW, et al. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. EClinicalMedicine 64: 102203 2023
    view publication
  • Stevens, NE, Ryan, FJ, Messina, NL, Blake, SJ, Norton, TS, Germano, S, James, J, Eden, GL, Tee, YC, Lynn, MA, et al. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines. Journal of Clinical Investigation 133(17) : e171742 2023
    view publication

Page 3 of 12